Iterum Therapeutics (ITRM)

AI Score

Unlock

1.23

0.06 (5.13%)

At close: Apr 02, 2025, 3:59 PM

1.24

1.10%

After-hours: Apr 02, 2025, 07:50 PM EDT

Iterum Therapeutics Cash Flow Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-24.77M	-38.37M	-44.43M	-91.56M	-52.01M	-103.13M	-77.06M	-29.41M	-13.46M
Depreciation & Amortization	30K	1.75M	1.8M	2.1M	161K	152K	136K	65K	n/a
Stock-Based Compensation	363K	784K	4.76M	4.32M	2.76M	2.17M	1.29M	392K	348K
Other Working Capital	-7.99M	540K	416K	-503K	-9.88M	6.45M	-2.45M	-3.27M	630K
Other Non-Cash Items	10.34M	-6.26M	17.09M	8.14M	17.71M	4.15M	2.04M	-95K	-830K
Deferred Income Tax	n/a	n/a	n/a	61.6M	1.41M	-125K	-701K	44K	n/a
Change in Working Capital	-12.73M	2.76M	2.31M	-440K	-24.56M	17.9M	-1.6M	-1.6M	1.82M
Operating Cash Flow	-26.77M	-39.33M	-18.47M	-15.84M	-54.53M	-78.89M	-75.89M	-30.6M	-11.3M
Capital Expenditures	-2K	-13K	-62K	-61K	-11K	-24K	-90K	-812K	n/a
Acquisitions	n/a	n/a	-14.02K	54.53K	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-12.39M	-41.18M	-45.71M	-67.03M	n/a	n/a	-96.49M	-53.27M	n/a
Sales Maturities Of Investments	30.6M	64.53M	59.73M	12.5M	n/a	40.13M	87.92M	22.5M	n/a
Other Investing Acitivies	n/a	n/a	14.02K	-54.53K	n/a	40.13K	-8.57K	-30.77K	n/a
Investing Cash Flow	18.21M	23.34M	13.96M	-54.59M	-11K	40.1M	-8.66M	-31.59M	n/a
Debt Repayment	n/a	n/a	-2.25M	-6.52M	-5.49M	-1.03M	14.51M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	26.69M	n/a	433K	n/a	n/a	60K	n/a	n/a	n/a
Financial Cash Flow	26.69M	1.03M	-1.82M	83.13M	64.47M	-974K	120.84M	45.87M	20.85M
Net Cash Flow	18.05M	-15.02M	-6.38M	12.69M	9.93M	-39.78M	36.19M	-16.32M	9.55M
Free Cash Flow	-26.77M	-39.34M	-18.54M	-15.9M	-54.54M	-78.91M	-75.98M	-31.42M	-11.3M